LISATA THERAPEUTICS, INC. — Director's Dealing 2014

Jul 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-07-08

Reporting Person: KLOSK STEVEN M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-08	Stock Option (right to purchase)	$5.98	A	18700	Acquired	2024-07-07	Common Stock, par value $0.001 per share (18700)	Direct

Footnotes

F1: Effective July 8, 2014 (the "Grant Date"), NeoStem, Inc. (the "Company") appointed Steven M. Klosk (the "Reporting Person") as a director of the Company. In connection with the appointment, the Reporting Person was granted an option to purchase 18,700 shares of the Company's common stock (the "Option"), subject to all of the terms and conditions of the Company's 2009 Amended & Restated Equity Compensation Plan and pursuant to the Company's Director Compensation Plan. The Option was fully vested on the Grant Date.